These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 26670365)

  • 41. Stimulus-Responsive Hydrogel for Ophthalmic Drug Delivery.
    Lin D; Lei L; Shi S; Li X
    Macromol Biosci; 2019 Jun; 19(6):e1900001. PubMed ID: 31026123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases.
    Zhao L; Song J; Du Y; Ren C; Guo B; Bi H
    Drug Deliv; 2023 Dec; 30(1):2219419. PubMed ID: 37264930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sustained drug release by contact lenses for glaucoma treatment-a review.
    Carvalho IM; Marques CS; Oliveira RS; Coelho PB; Costa PC; Ferreira DC
    J Control Release; 2015 Mar; 202():76-82. PubMed ID: 25617723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ophthalmic Sensors and Drug Delivery.
    Dennyson Savariraj A; Salih A; Alam F; Elsherif M; AlQattan B; Khan AA; Yetisen AK; Butt H
    ACS Sens; 2021 Jun; 6(6):2046-2076. PubMed ID: 34043907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ophthalmic gels: Past, present and future.
    Al-Kinani AA; Zidan G; Elsaid N; Seyfoddin A; Alani AWG; Alany RG
    Adv Drug Deliv Rev; 2018 Feb; 126():113-126. PubMed ID: 29288733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases.
    Fang G; Yang X; Wang Q; Zhang A; Tang B
    Mater Sci Eng C Mater Biol Appl; 2021 Aug; 127():112212. PubMed ID: 34225864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental studies on soft contact lenses for controlled ocular delivery of pirfinedone: in vitro and in vivo.
    Yang M; Yang Y; Lei M; Ye C; Zhao C; Xu J; Wu K; Yu M
    Drug Deliv; 2016 Nov; 23(9):3538-3543. PubMed ID: 27331555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery.
    Singh M; Bharadwaj S; Lee KE; Kang SG
    J Control Release; 2020 Dec; 328():895-916. PubMed ID: 33069743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical delivery of ocular therapeutics: carrier systems and physical methods.
    Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF
    J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug loading optimization and extended drug delivery of corticoids from pHEMA based soft contact lenses hydrogels via chemical and microstructural modifications.
    García-Millán E; Koprivnik S; Otero-Espinar FJ
    Int J Pharm; 2015 Jun; 487(1-2):260-9. PubMed ID: 25891253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular Drug Delivery: Present Innovations and Future Challenges.
    Gote V; Sikder S; Sicotte J; Pal D
    J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery.
    Silva B; São Braz B; Delgado E; Gonçalves L
    Int J Pharm; 2021 Sep; 606():120873. PubMed ID: 34246741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In situ-forming hydrogels for sustained ophthalmic drug delivery.
    Nanjawade BK; Manvi FV; Manjappa AS
    J Control Release; 2007 Sep; 122(2):119-34. PubMed ID: 17719120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bovine serum albumin-meloxicam nanoaggregates laden contact lenses for ophthalmic drug delivery in treatment of postcataract endophthalmitis.
    Zhang W; Zu D; Chen J; Peng J; Liu Y; Zhang H; Li S; Pan W
    Int J Pharm; 2014 Nov; 475(1-2):25-34. PubMed ID: 25158220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Commercialization challenges for drug eluting contact lenses.
    Lanier OL; Christopher KG; Macoon RM; Yu Y; Sekar P; Chauhan A
    Expert Opin Drug Deliv; 2020 Aug; 17(8):1133-1149. PubMed ID: 32602822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies.
    Mofidfar M; Abdi B; Ahadian S; Mostafavi E; Desai TA; Abbasi F; Sun Y; Manche EE; Ta CN; Flowers CW
    Int J Pharm; 2021 Sep; 607():120924. PubMed ID: 34324989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ocular delivery systems for topical application of anti-infective agents.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
    Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond.
    Destruel PL; Zeng N; Maury M; Mignet N; Boudy V
    Drug Discov Today; 2017 Apr; 22(4):638-651. PubMed ID: 28017837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
    Jung HJ; Chauhan A
    Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring the Potential of Nanoporous Materials for Advancing Ophthalmic Treatments.
    Wu KY; Brister D; Bélanger P; Tran SD
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.